193 related articles for article (PubMed ID: 38534322)
21. Monoclonal antibody therapy in COVID-19.
Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
[TBL] [Abstract][Full Text] [Related]
22. β-Amyloid in blood neuronal-derived extracellular vesicles is elevated in cognitively normal adults at risk of Alzheimer's disease and predicts cerebral amyloidosis.
Li TR; Yao YX; Jiang XY; Dong QY; Yu XF; Wang T; Cai YN; Han Y
Alzheimers Res Ther; 2022 May; 14(1):66. PubMed ID: 35550625
[TBL] [Abstract][Full Text] [Related]
23. Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19.
Charnley M; Islam S; Bindra GK; Engwirda J; Ratcliffe J; Zhou J; Mezzenga R; Hulett MD; Han K; Berryman JT; Reynolds NP
Nat Commun; 2022 Jun; 13(1):3387. PubMed ID: 35697699
[TBL] [Abstract][Full Text] [Related]
24. Neuroinflammation in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection: Pathogenesis and clinical manifestations.
Cárdenas G; Fragoso G; Sciutto E
Curr Opin Pharmacol; 2022 Apr; 63():102181. PubMed ID: 35074661
[TBL] [Abstract][Full Text] [Related]
25. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
Xie Y; Choi T; Al-Aly Z
JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
[TBL] [Abstract][Full Text] [Related]
26. Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons.
Kong W; Montano M; Corley MJ; Helmy E; Kobayashi H; Kinisu M; Suryawanshi R; Luo X; Royer LA; Roan NR; Ott M; Ndhlovu LC; Greene WC
mBio; 2022 Dec; 13(6):e0230822. PubMed ID: 36314791
[TBL] [Abstract][Full Text] [Related]
27. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
[TBL] [Abstract][Full Text] [Related]
28. Circulatory Exosomes from COVID-19 Patients Trigger NLRP3 Inflammasome in Endothelial Cells.
Sur S; Steele R; Isbell TS; Ray R; Ray RB
mBio; 2022 Jun; 13(3):e0095122. PubMed ID: 35587188
[TBL] [Abstract][Full Text] [Related]
29. Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection.
Fong SW; Goh YS; Torres-Ruesta A; Chang ZW; Chan YH; Neo VK; Lee B; Duan K; Amrun SN; Yeo NK; Chen HV; Tay MZ; Carissimo G; ; ; Tan SY; Leo YS; Lye DC; Renia L; Young BE; Ng LFP
J Med Virol; 2023 May; 95(5):e28774. PubMed ID: 37212320
[TBL] [Abstract][Full Text] [Related]
30. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences.
Rahmati M; Udeh R; Yon DK; Lee SW; Dolja-Gore X; McEVoy M; Kenna T; Jacob L; López Sánchez GF; Koyanagi A; Shin JI; Smith L
J Med Virol; 2023 Jun; 95(6):e28852. PubMed ID: 37288652
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.
Chiricosta L; Gugliandolo A; Mazzon E
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948400
[TBL] [Abstract][Full Text] [Related]
32. Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review.
Jumagaliyeva M; Ayaganov D; Saparbayev S; Tuychibaeva N; Abdelazim IA; Kurmambayev Y; Khamidullina Z; Yessenamanova S
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9420-9428. PubMed ID: 37843354
[TBL] [Abstract][Full Text] [Related]
33. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
Najjar S; Najjar A; Chong DJ; Pramanik BK; Kirsch C; Kuzniecky RI; Pacia SV; Azhar S
J Neuroinflammation; 2020 Aug; 17(1):231. PubMed ID: 32758257
[TBL] [Abstract][Full Text] [Related]
34. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
35. Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.
Eckhardt CM; Cummings MJ; Rajagopalan KN; Borden S; Bitan ZC; Wolf A; Kantor A; Briese T; Meyer BJ; Jacobson SD; Scotto D; Mishra N; Philip NM; Stotler BA; Schwartz J; Shaz B; Spitalnik SL; Eisenberger A; Hod EA; Justman J; Cheung K; Lipkin WI; O'Donnell MR
Trials; 2020 Jun; 21(1):499. PubMed ID: 32513308
[TBL] [Abstract][Full Text] [Related]
36. Morphological, cellular, and molecular basis of brain infection in COVID-19 patients.
Crunfli F; Carregari VC; Veras FP; Silva LS; Nogueira MH; Antunes ASLM; Vendramini PH; Valença AGF; Brandão-Teles C; Zuccoli GDS; Reis-de-Oliveira G; Silva-Costa LC; Saia-Cereda VM; Smith BJ; Codo AC; de Souza GF; Muraro SP; Parise PL; Toledo-Teixeira DA; Santos de Castro ÍM; Melo BM; Almeida GM; Firmino EMS; Paiva IM; Silva BMS; Guimarães RM; Mendes ND; Ludwig RL; Ruiz GP; Knittel TL; Davanzo GG; Gerhardt JA; Rodrigues PB; Forato J; Amorim MR; Brunetti NS; Martini MC; Benatti MN; Batah SS; Siyuan L; João RB; Aventurato ÍK; Rabelo de Brito M; Mendes MJ; da Costa BA; Alvim MKM; da Silva Júnior JR; Damião LL; de Sousa IMP; da Rocha ED; Gonçalves SM; Lopes da Silva LH; Bettini V; Campos BM; Ludwig G; Tavares LA; Pontelli MC; Viana RMM; Martins RB; Vieira AS; Alves-Filho JC; Arruda E; Podolsky-Gondim GG; Santos MV; Neder L; Damasio A; Rehen S; Vinolo MAR; Munhoz CD; Louzada-Junior P; Oliveira RD; Cunha FQ; Nakaya HI; Mauad T; Duarte-Neto AN; Ferraz da Silva LF; Dolhnikoff M; Saldiva PHN; Farias AS; Cendes F; Moraes-Vieira PMM; Fabro AT; Sebollela A; Proença-Modena JL; Yasuda CL; Mori MA; Cunha TM; Martins-de-Souza D
Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2200960119. PubMed ID: 35951647
[TBL] [Abstract][Full Text] [Related]
37. Long-term complications after infection with SARS-CoV-1, influenza and MERS-CoV - Lessons to learn in long COVID?
Løkke FB; Hansen KS; Dalgaard LS; Öbrink-Hansen K; Schiøttz-Christensen B; Leth S
Infect Dis Now; 2023 Oct; 53(8):104779. PubMed ID: 37678512
[TBL] [Abstract][Full Text] [Related]
38. Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection.
Tso WW; Kwan MY; Kwok JS; Tsang JO; Yip CC; Leung LK; Li C; Wang Y; Chow MS; Tsang AM; Chim S; Chow CY; Ho AC; Chan SH; Tai SM; Lee WC; Chan VC; Yau EK; Sun JK; Chow HM; Lau YL; Ip P; Chan JF
J Med Virol; 2023 Jul; 95(7):e28895. PubMed ID: 37403902
[TBL] [Abstract][Full Text] [Related]
39. New‑onset neuropsychiatric sequelae and 'long‑COVID' syndrome (Review).
Efstathiou V; Stefanou MI; Demetriou M; Siafakas N; Katsantoni E; Makris M; Tsivgoulis G; Zoumpourlis V; Kympouropoulos SP; Tsoporis JN; Spandidos DA; Ferentinos P; Smyrnis N; Rizos E
Exp Ther Med; 2022 Nov; 24(5):705. PubMed ID: 36324612
[TBL] [Abstract][Full Text] [Related]
40. [Clinical features of children with coronavirus disease 2019 Delta variant infection after vaccination with inactivated SARS-CoV-2 vaccine].
Su H; Zhang X; Duan FY; Ren XQ; Yan YB; Ding Y
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):742-747. PubMed ID: 35894187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
